Ethic Inc. Takeda Pharmaceutical CO LTD Transaction History

Ethic Inc.

$4.8 Billion
Q1 2025

A detailed history of Ethic Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Ethic Inc. holds 219,535 shares of TAK stock, worth $3.37 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

219,535

Previous 326,307 32.72%

Holding current value

$3.37 Million

Previous $4.32 Million 24.44%

% of portfolio

0.07%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$12.89 - $15.19 $1.38 Million - $1.62 Million	-106,772 Reduced 32.72%	219,535 $3.26 Million
Q4 2024 Feb 14, 2025	SELL	$13.01 - $14.43 $1.48 Million - $1.64 Million	-113,512 Reduced 25.81%	326,307 $4.32 Million
Q3 2024 Nov 13, 2024	SELL	$13.0 - $15.08 $208,715 - $242,109	-16,055 Reduced 3.52%	439,819 $6.25 Million
Q2 2024 Aug 13, 2024	BUY	$12.6 - $13.67 $202,293 - $219,471	16,055 Added 3.65%	455,874 $5.9 Million
Q1 2024 May 13, 2024	BUY	$13.89 - $15.04 $1.03 Million - $1.12 Million	74,488 Added 20.39%	439,819 $6.11 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $1.29 Million - $1.49 Million	-96,516 Reduced 20.9%	365,331 $5.21 Million
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $885,943 - $961,982	58,945 Added 14.63%	461,847 $7.14 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $733,705 - $806,274	47,123 Added 13.25%	402,902 $6.33 Million
Q1 2023 May 12, 2023	BUY	$15.28 - $16.48 $931,636 - $1 Million	60,971 Added 20.68%	355,779 $5.86 Million
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $1.93 Million - $2.43 Million	155,562 Added 111.72%	294,808 $4.6 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $251,097 - $562,027	-19,617 Reduced 12.35%	139,246 $1.81 Million
Q2 2022 Aug 10, 2022	SELL	$13.12 - $15.03 $1.15 Million - $1.32 Million	-87,765 Reduced 35.59%	158,863 $2.23 Million
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $1.45 Million - $1.64 Million	106,763 Added 76.33%	246,628 $3.53 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $663,557 - $826,297	50,384 Added 56.31%	139,865 $1.91 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $354,492 - $375,370	21,748 Added 32.11%	89,481 $1.47 Million
Q2 2021 Aug 10, 2021	BUY	$16.55 - $18.64 $172,748 - $194,564	10,438 Added 18.22%	67,733 $1.14 Million
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $356,758 - $424,864	21,350 Added 59.4%	57,295 $1.05 Million
Q4 2020 Feb 10, 2021	BUY	$15.39 - $18.97 $4,847 - $5,975	315 Added 0.88%	35,945 $654,000
Q3 2020 Oct 27, 2020	BUY	$17.1 - $19.19 $142,716 - $160,159	8,346 Added 30.59%	35,630 $636,000
Q2 2020 Aug 12, 2020	BUY	$14.59 - $19.5 $74,233 - $99,216	5,088 Added 22.92%	27,284 $489,000
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $51,520 - $80,366	3,957 Added 21.7%	22,196 $337,000
Q4 2019 May 22, 2020	BUY	$16.88 - $20.83 $46,318 - $57,157	2,744 Added 17.71%	18,239 $360,000
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $261,555 - $322,760	15,495 New	15,495 $306,000

Others Institutions Holding TAK

# of Institutions

360

Shares Held

67.4M

Call Options Held

1.72M

Put Options Held

186K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $47.8B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account